表观扩散系数用于鉴别头颈部癌治疗后改变与复发:系统评价与Meta分析
该系统评价与Meta分析纳入6项前瞻性研究共365例患者(402个病灶),汇总复发灶ADC均值为1.03×10⁻³mm²/s,治疗后改变为1.51×10⁻³mm²/s,复发灶ADC显著低于治疗后改变(汇总均数差-0.45,95%CI -0.59至-0.32,P<.0001),研究间存在异质性,作者提出两者间ADC阈值建议为1.10×10⁻³mm²/s。
要点
- 复发灶ADC均值1.03×10⁻³mm²/s,低于治疗后改变的1.51×10⁻³mm²/s。
- 汇总均数差-0.45(95%CI -0.59至-0.32,P<.0001),研究间存在异质性。
- 作者建议两者间ADC阈值取1.10×10⁻³mm²/s。
核心结论
- 复发头颈部癌ADC值低于治疗后改变,作者据此提出了两者间的ADC阈值建议。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Scopus和EMBASE数据库。
- 纳入6项前瞻性研究,共365例患者、402个病灶。
关键影像表现/征象
- 复发灶ADC总体均值为1.03×10⁻³mm²/s,治疗后改变为1.51×10⁻³mm²/s。
诊断标准与关键数值
- 复发灶与治疗后改变之间ADC阈值作者建议为1.10×10⁻³mm²/s。
- 复发灶ADC显著低于治疗后改变,汇总均数差-0.45(95%CI -0.59至-0.32,P<.0001)。
临床应用与阅片要点
- 原文结论为复发头颈部癌ADC值低于治疗后改变,并提出了两者间的ADC阈值建议。
局限性
- 鉴于研究数据的异质性,结论应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Previous studies reported that the ADC values of recurrent head and neck cancer lesions are lower than those of posttreatment changes, however, the utility of ADC to differentiate them has not been definitively summarized and established.
PURPOSE: Our aim was to evaluate the diagnostic benefit of ADC calculated from diffusion-weighted imaging in differentiating recurrent lesions from posttreatment changes in head and neck cancer.
DATA SOURCES: MEDLINE, Scopus, and EMBASE data bases were searched for studies.
STUDY SELECTION: The review identified 6 prospective studies with a total of 365 patients (402 lesions) who were eligible for the meta-analysis.
DATA ANALYSIS: Forest plots were used to assess the mean difference in ADC values. Heterogeneity among the studies was evaluated using the Cochrane Q test and the I2 statistic.
DATA SYNTHESIS: Among included studies, the overall mean of ADC values of recurrent lesions was 1.03 × 10-3mm2/s and that of the posttreatment changes was 1.51 × 10-3mm2/s. The ADC value of recurrence was significantly less than that of posttreatment changes in head and neck cancer (pooled mean difference: -0.45; 95% CI, -0.59-0.32, P < .0001) with heterogeneity among studies. The threshold of ADC values between recurrent lesions and posttreatment changes was suggested to be 1.10 × 10-3mm2/s.
LIMITATIONS: Given the heterogeneity of the data of the study, the conclusions should be interpreted with caution.
CONCLUSIONS: The ADC values in recurrent head and neck cancers are lower than those of posttreatment changes, and the threshold of ADC values between them was suggested.
引用
- Baba, Kurokawa, Kurokawa, et al. ADC for Differentiation between Posttreatment Changes and Recurrence in Head and Neck Cancer: A Systematic Review and Meta-analysis. AJNR Am J Neuroradiol. 2022. PMID: 35210272. doi:10.3174/ajnr.A7431
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。